X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-27 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $1.02 | +2,500 | 57,880 | +5% | +$2,550 | ||||||
2023-09-26 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.90 | +2,500 | 55,380 | +5% | +$2,250 | ||||||
2023-04-26 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $1.77 | +1,497 | 7,013 | +27% | +$2,650 | ||||||
2023-04-25 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $1.89 | +1,315 | 5,516 | +31% | +$2,485 | ||||||
2022-07-27 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.38 | +2,500 | 226,705 | +1% | +$950 | ||||||
2022-07-26 | WINT | Hamill John P. | SVP, CFO | P - Purchase | $0.37 | +3,000 | 72,800 | +4% | +$1,100 | ||||||
2022-07-26 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.37 | +2,500 | 224,205 | +1% | +$935 | ||||||
2022-06-30 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.43 | +4,500 | 221,705 | +2% | +$1,926 | ||||||
2022-06-29 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.42 | +7,000 | 217,205 | +3% | +$2,908 | ||||||
2022-03-16 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.98 | +2,000 | 210,205 | +1% | +$1,960 | ||||||
2022-03-15 | WINT | Simonson Steven | SVP, Chief Medical Officer | P - Purchase | $1.00 | +5,000 | 83,894 | +6% | +$4,999 | ||||||
2022-03-15 | WINT | Fraser Craig | Pres, CEO | P - Purchase | $0.98 | +3,000 | 208,205 | +1% | +$2,940 | ||||||
| DM | 2020-05-20 | WINT | Center Laboratories, Inc. | 10% | P - Purchase | $1.84 | +1,294,260 | 2,478,176 | +109% | +$2,382,538 | |||||
| D | 2020-05-20 | WINT | Bioengine Capital Inc. | 10% | P - Purchase | $7.25 | +55,172 | 0 | -100% | +$399,997 | |||||
| D | 2021-12-30 | WINT | Bioengine Capital Inc. | 10% | S - Sale+OE | $1.60 | -1,239,088 | 0 | -100% | -$1,982,541 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |